Chien‐Wen Chang

3.7k total citations
67 papers, 3.0k citations indexed

About

Chien‐Wen Chang is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Chien‐Wen Chang has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Biomedical Engineering, 28 papers in Molecular Biology and 16 papers in Biomaterials. Recurrent topics in Chien‐Wen Chang's work include RNA Interference and Gene Delivery (17 papers), Nanoplatforms for cancer theranostics (15 papers) and Nanoparticle-Based Drug Delivery (13 papers). Chien‐Wen Chang is often cited by papers focused on RNA Interference and Gene Delivery (17 papers), Nanoplatforms for cancer theranostics (15 papers) and Nanoparticle-Based Drug Delivery (13 papers). Chien‐Wen Chang collaborates with scholars based in Taiwan, United States and South Korea. Chien‐Wen Chang's co-authors include Heather D. Maynard, Shyni Varghese, Sung Wan Kim, Won Jong Kim, Chao Zhang, Lane V. Christensen, Lei Tao, Wen‐Hsuan Chiang, Thi H. Nguyen and David A. Bull and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Advanced Functional Materials.

In The Last Decade

Chien‐Wen Chang

65 papers receiving 3.0k citations

Peers

Countries citing papers authored by Chien‐Wen Chang

Since Specialization

Citations

This map shows the geographic impact of Chien‐Wen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Wen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Wen Chang more than expected).

Fields of papers citing papers by Chien‐Wen Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Wen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Wen Chang. The network helps show where Chien‐Wen Chang may publish in the future.

Co-authorship network of co-authors of Chien‐Wen Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Wen Chang. A scholar is included among the top collaborators of Chien‐Wen Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Wen Chang. Chien‐Wen Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Programmed Lung Metastasis Immunotherapy via Cascade‐Responsive Cell Membrane‐Mimetic Copolymer‐Wrapped Nanoraspberry‐Mediated Elesclomol‐Copper Delivery 2024 ·Advanced Functional Materials ·Thi My Hue Huynh, (unknown), (unknown), (unknown), Chien‐Wen Chang, Wen‐Hsuan Chiang, Yu‐Chen Liu, Chun‐Yu Chuang, Chia‐Chih Chang, Shang‐Hsiu Hu	49
2	2232O Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031 2023 ·Annals of Oncology ·Nadia Harbeck, Chaojun Duan, Kelly DuPree, Chien‐Wen Chang, Carlos H. Barrios, (unknown), Shigehira Saji, Keun‐Hwa Jung, (unknown), (unknown), Jane Yuet Ching Hui, (unknown), EA Mittendorf, Luciana Molinero	0
3	Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges 2023 ·Journal of Controlled Release ·(unknown), Wei‐Ting Shen, (unknown), (unknown), (unknown), Chien‐Wen Chang, Wen‐Hsuan Chiang, Yu‐Chen Liu, Shing‐Jyh Chang, Shang‐Hsiu Hu	22
4	Isolation and characterizations of multidrug-resistant human cancer cells by a biodegradable nano-sensor 2023 ·Biosensors and Bioelectronics ·(unknown), (unknown), (unknown), (unknown), Cheng–Yuan Kao, Chien‐Wen Chang	3
5	3D-Bioprinted GelMA Scaffold with ASCs and HUVECs for Engineering Vascularized Adipose Tissue 2023 ·ACS Applied Bio Materials ·Ming‐Huei Cheng, Chien‐Wen Chang, (unknown), (unknown), Wei Huang, Chih-Hsin Lin	7
6	Programmed Catalytic Therapy and Antigen Capture‐Mediated Dendritic Cells Harnessing Cancer Immunotherapies by In Situ‐Forming Adhesive Nanoreservoirs (Adv. Funct. Mater. 15/2023) 2023 ·Advanced Functional Materials ·(unknown), Thi My Hue Huynh, (unknown), (unknown), Chien‐Wen Chang, Wen‐Hsuan Chiang, Shang‐Hsiu Hu	2
7	Programmed antigen capture-harnessed dendritic cells by margination-hitchhiking lung delivery 2023 ·Journal of Controlled Release ·Thi My Hue Huynh, (unknown), (unknown), (unknown), Chien‐Wen Chang, Wen‐Hsuan Chiang, Lun‐De Liao, Yu‐Chen Liu, Shang‐Hsiu Hu	17
8	Magnetic nanocomplexes for gene delivery applications 2021 ·Journal of Materials Chemistry B ·(unknown), Zhuo‐Hao Liu, (unknown), Chien‐Wen Chang	26
9	Arginine-tocopherol bioconjugated lipid vesicles for selective pTRAIL delivery and subsequent apoptosis induction in glioblastoma cells 2021 ·Materials Science and Engineering C ·(unknown), Yu‐Lun Lo, Yiting Wu, Chien‐Wen Chang, (unknown), Li‐Fang Wang	17
10	Magnetic ternary nanohybrids for nonviral gene delivery of stem cells and applications on cancer therapy 2019 ·Theranostics ·(unknown), (unknown), (unknown), Yinan Li, Chi‐Shiun Chiang, Chien‐Wen Chang	40
11	Reactive stroma mediates CD8+ T cell spatial distribution and function in ovarian cancer 2017 ·Annals of Oncology ·(unknown), Lisa Ryner, Ameya Udyavar, Mélanie Desbois, Cleopatra Kozlowski, Chien‐Wen Chang, Yinghui Guan, Shan Lu, Hartmut Koeppen, James Ziai, Richard Bourgon, Priti S. Hegde	1
12	Multifunctional PEGylated Albumin/IR780/Iron Oxide Nanocomplexes for Cancer Photothermal Therapy and MR Imaging 2017 ·Nanotheranostics ·(unknown), (unknown), Weichen Liao, (unknown), Chien‐Wen Chang	31
13	Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics 2016 ·Biomaterials ·(unknown), Chen‐Hsiang Kuan, Liwen Wang, Hsi‐Chin Wu, Yunching Chen, Chien‐Wen Chang, (unknown), Tzu‐Wei Wang	64
14	Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model 2015 ·International Journal of Nanomedicine ·(unknown), Te‐Wei Lee, Chih-Hsien Chang, Liang‐Cheng Chen, Wei‐Hsin Hsu, Chien‐Wen Chang, Jem‐Mau Lo	30
15	Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia 2015 ·Journal of Controlled Release ·Wen‐Chia Huang, Ming‐Yin Shen, Hsin‐Hung Chen, Sung‐Chyr Lin, Wen‐Hsuan Chiang, Pei-Hsuan Wu, Chien‐Wen Chang, Chi‐Shiun Chiang, Hsin‐Cheng Chiu	59
16	48.1: Invited Paper : Design and Manufacture of a Slim Notebook Embedded Touch Panel 2014 ·SID Symposium Digest of Technical Papers ·Andre Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chien‐Wen Chang, (unknown)	2
17	Engineering cell–material interfaces for long-term expansion of human pluripotent stem cells 2012 ·Biomaterials ·Chien‐Wen Chang, Yongsung Hwang, David A. Brafman, Thomas Hagan, (unknown), Shyni Varghese	46
18	Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct 2008 ·Gene Therapy ·James W. Yockman, Donghoon Choi, (unknown), Chien‐Wen Chang, Andrew Kastenmeier, (unknown), (unknown), (unknown), (unknown), David A. Bull	49
19	Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma 2007 ·Gene Therapy ·James W. Yockman, Woo Jin Kim, Chien‐Wen Chang, (unknown)	9
20	Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery 2006 ·Journal of Controlled Release ·Lane V. Christensen, Chien‐Wen Chang, James W. Yockman, (unknown), Heidi H. Jackson, Zhiyuan Zhong, Jan Feijén, David A. Bull, Sung Wan Kim	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact